Effect of Ultrasound and Mixing of Folate and Trastuzumab Liposomes on DOX Release and Cellular Uptake

This study explores the potential of physically mixing individually targeted Doxorubicin (DOX)-loaded liposomes functionalized with folic acid (FA) and trastuzumab (TRA), combined with ultrasound (US) triggering, to enhance targeted breast cancer therapy. This research focused on synthesizing, characterizing, and evaluating DOX release, cellular uptake, and cytotoxicity of FA-PEG and TRA-PEG-modified liposomes mixed at different volume fractions. Low-frequency ultrasound (LFUS) and high-frequency ultrasound (HFUS) were employed to trigger DOX release. The study demonstrated that the sonicated-physically-mixed liposomes showed superior release performance (specifically the M75 group) and increased cellular uptake (specifically the M25 group) compared to individually targeted liposomes, highlighting their combined potential in breast cancer treatment.